News

Discover the latest advancements in dermatology in our June issue, including FDA approvals, innovative treatments, and expert insights shaping patient care today.

In part 2 of this conversation, Adam Friedman, MD, FAAD, discusses new data on lichen planus treatment trends, unmet needs, and the promise of innovative therapies.

Sagimet Biosciences reveals denifanstat's promising phase 3 results, offering a novel oral treatment for moderate to severe acne with significant efficacy.

This review of the latest dermatologic studies includes insights into clinical manifestations of mpox infection, therapeutic modulation of Demodex density via isotretinoin, and more.

Catch up on dermatology news, highlights, and insights from the past 24 hours.

New research highlights the importance of tinted sunscreens with iron oxides for effective protection against visible light-induced skin pigmentation, especially for darker skin tones.

Jonathan Silverberg, MD, PhD, MPH, shares his insights on treating and managing CHE.

The National Psoriasis Foundation Seal of Recognition program has expanded to prescription drugs, making roflumilast the first to achieve the indication.

Through a comprehensive review and meta-analysis, researchers identified the correlation between atopic dermatitis and dementia.

Explore cutting-edge insights and networking opportunities at this year's Fall Clinical Dermatology Conference for PAs and NPs, focusing on dermatology education and innovative treatments.

Friedman discusses survey findings revealing inconsistent screening, outdated assumptions, and lack of FDA-approved therapies for lichen planus.

Catch up on dermatology news, highlights, and insights from the past 24 hours.

Catch up on coverage from the last day of the 2025 Fall Clinical Dermatology Conference for PAs and NPs held in Orlando, Florida.

Clinicians learn to navigate salary negotiations and contracts effectively, focusing on value and strategic insights for career empowerment.

Heather Gates, PA-C, shares insights on the importance of continuous learning, mentorship, and legislative reform for PAs and NPs in dermatology.

Explore the top headlines of the week including insights on the latest clinical trials, therapeutic updates, and more.

Evan Rieder, MD, shares effective strategies to enhance dermatology practice efficiency by addressing psychological aspects of patient care and setting professional boundaries.

Test your knowledge of key words and terms associated with dermatology news from the previous week.

Recludix advances REX-8756, a first-in-class oral STAT6 inhibitor, showing promise for safer, targeted treatment of type 2 inflammatory skin diseases.

Discover essential business metrics for PAs in dermatology, empowering practice ownership and driving sustainable growth through data-driven strategies.

Dermatology Times has compiled a list of dermatological meetings taking place during the month of June.

Catch up on coverage from the third day of the 2025 Fall Clinical Dermatology Conference for PAs and NPs held in Orlando, Florida.

Discover innovative strategies for AK treatment from Darrell Rigel, MD, MS, at the latest Fall Clinical PA/NP conference.

Discover the latest advancements in aesthetics as Heather Gates, PA-C, shares innovative techniques and emerging technologies from this groundbreaking workshop.

Ben Lockshin, MD, FAAD, covered ways in which GLP-1 RAs can be utilized when treating psoriatic disease.

Chronic hand eczema poses diagnostic challenges and impacts quality of life, but emerging JAK inhibitors offer promising new treatment options.

Catch up on coverage from the second day of the 2025 Fall Clinical Dermatology Conference for PAs and NPs held in Orlando, Florida.

At the Fall Clinical PA/NP 2025 meeting, James Del Rosso, DO, spoke about recently approved therapies like JAKis for alopecia, biologics for AD, and tirbanibulin for AKs.

At this year's Fall Clinical PA/NP meeting, Darrell Rigel, MD, MS, spoke about the evolving role of GEP in managing melanoma and squamous cell carcinoma.

Kristine Kucera, PA-C, MPAS, DHS, highlights the enduring importance of traditional systemic therapies in dermatology, emphasizing their clinical utility amidst emerging treatments.